Prostate Cancer Summit update
Under the 2018 Optimal Care Pathways Implementation Program Integrated Cancer Services will support local teams to identify opportunities for optimizing cancer care.
In its first phase the program will focus on investigating:
- whether men with prostate cancer are routinely provided with an opportunity to explore all available management options?
- is appropriate support accessible to meet men’s supportive care needs in the acute and survivorship phase following treatment?
- rates of multidisciplinary meeting discussion of cases before starting treatment.
- the extent to which Victorian GPs are aware and adhere to the NHMRC PSA testing and early management of test detected prostate cancer guidelines.
This will involve process mapping existing services and referral pathways both within hospitals and in the community and collecting data on patients’ experience of care.
The Prostate Cancer Outcomes Registry (PCOR) ANZ collects outcomes data for around 78 per cent of men diagnosed with prostate cancer in Victoria.
This data is useful in identifying the extent to which care aligns with some aspects of the prostate cancer optimal care pathway. Clinicians are encouraged to use PCOR data to inform their optimal care pathway service improvement.
For more information contact your local ICS
Watch the prostate cancer summit data presentation
About the Summit
Seventy-one delegates providing care or support to men with prostate cancer attended the summit on Friday 27th May to discuss and identify unwarranted variations in practice and cancer outcomes that could be addressed through state-wide action.
Professor Robert Thomas, Chief Advisor on Cancer (DHHS), opened the event and introduced the Prostate Cancer Optimal Care Pathway (OCP), highlighting the role of collaboration in addressing variations in cancer care for men with prostate cancer. Prof. Damien Bolton, Co-Chair of the Prostate Summit Working Party, set the scene and outlined the purpose of the day. A/Prof Jeremy Millar, Co-Chair of the Prostate Summit Working Party, presented available data on incidence, survival, disease characteristics and treatment planning of men with prostate cancer across Victoria. View the prostate summit presentation.
A summary of variations in practice and outcomes for Victorian men with prostate cancer was available to participants as a reference.
Prostate cancer care in Victoria presentation highlights:
- Age-standardised incidence of prostate cancer fell 39% from 2009-2014. This is highly correlated with the decreasing number of PSA tests
- Age-standardised mortality of prostate cancer increased from 1982-1994, then fell 2.5% per annum from 1994-2014
- Lower age-standardised incidence in GRICS and WCMICS, and higher in NEMICS and SMICS. This is partly explained by the higher incidences at higher Socio-economic Status (SES)
- Men in regional areas are more likely to present with symptoms, have a TURP for diagnosis, and have metastatic and high-risk disease
- In regional areas men are less likely to be recorded as discussed in an MDM, and time from diagnosis to treatment is longer
- Prostatectomies are the most common treatment, performed in 42 hospitals, more commonly in metro and private facilities
- Large variation in modalities of treatment across state even for similar risk disease
- Large variation in age-standardised mortality across regions associated with large variation in populations, disease presentation, access to care, and types of care available
Following the data presentation delegates engaged in small group discussions to identify state or local opportunities for action.
Prostate Summit Working Party
|Prof Jeremy Millar||Prof Damien Bolton||A/Prof Paul Mitchell|
|A/Prof Declan Murphy||A/Prof Justin Tse||Prof Ian Davis|
|A/Prof Sue Evans||Dr Keen-Hun Tai||Dr David Pook|
|Mr Mark Frydenberg||Mr Paul Kearns||Mr Rohan Hall|
|Mr Nathan Lawrentschuk||Dr Mahesh Iddawela||Mr Lachlan Dodds|
|Ms Mirela Matthews||Ms Melinda Williams||Mr Luc te Marvelde|
|Mr Don Vincendese||Ms Ella Stuart||Ms Megan Dendle|